Biotech NewsEx-Lilly CEO Josh Bilenker & Ex-Novartis Head of Oncology Jeff Engelman Announce Treeline Biosciences Jak ThomsonApril 30, 2021 Two powerhouse executives have joined forces to form a brand new cancer Biotech company. Josh Bilenker, M.D., and… 0 Shares 0 0 0 0 0 0 0
Biotech NewsRepertoire Immune Medicines Enters Collaboration with Yale to Research Multiple Sclerosis Novel Antigen Discovery & T Cell Receptors BioTech Health XApril 29, 2021 The collaboration between Repertoire and Yale seeks to identify novel antigenic reactivity of T cells in patients with… 0 Shares 0 0 0 0 0 0 0